Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 7517358, 10 pages
https://doi.org/10.1155/2017/7517358
Research Article

Astragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII

1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
2Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China
3Department of Medicine, Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292, USA
4Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
5College of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Yibing Nong; ude.ellivsiuol@gnon.gnibiy and Qian Lin; moc.621@26naiqnil

Received 26 May 2017; Accepted 6 July 2017; Published 10 August 2017

Academic Editor: Manel Santafe

Copyright © 2017 Sinai Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Lorenz, K. Stathopoulou, E. Schmid, P. Eder, and F. Cuello, “Heart failure-specific changes in protein kinase signalling,” Pflugers Archiv European Journal of Physiology, vol. 466, no. 6, pp. 1151–1162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Coronel, R. Wilders, A. O. Verkerk, R. F. Wiegerinck, D. Benoist, and O. Bernus, “Electrophysiological changes in heart failure and their implications for arrhythmogenesis,” Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1832, no. 12, pp. 2432–2441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Wang and J. A. Hill, “Electrophysiological remodeling in heart failure,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 619–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W.-D. Zhang, H. Chen, C. Zhang, R. H. Liu, H. L. Li, and H. Z. Chen, “Astragaloside IV from astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro,” Planta Medica, vol. 72, no. 1, pp. 4–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. X.-L. Xu, X.-J. Chen, H. Ji et al., “Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca2+-ATPase,” Pharmacology, vol. 81, no. 4, pp. 325–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Wang, Y. Ji, Y. Xing, X. Li, and X. Gao, “Astragalosides rescue both cardiac function and sarcoplasmic reticulum Ca2+ transport in rats with chronic heart failure,” Phytotherapy Research, vol. 26, no. 2, pp. 231–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Q.-Y. Yang, K.-J. Chen, S. Lu, and H.-R. Sun, “Research progress on mechanism of action of radix astragalus in the treatment of heart failure,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 235–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Dai, G. Jia, X. Liu, Z. Liu, and H. Wang, “Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca2+-mediated calcineurin/NFATc3 and CaMKII signaling cascades,” Environmental Toxicology and Pharmacology, vol. 38, no. 1, pp. 263–271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Q.-Y. Yang, S. Lu, and H.-R. Sun, “Clinical effect of astragalus granule of different dosages on quality of life in patients with chronic heart failure,” Chinese Journal of Integrative Medicine, vol. 17, no. 2, pp. 146–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Wang, S. Tandan, J. Cheng et al., “Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure,” Journal of Biological Chemistry, vol. 283, no. 37, pp. 25524–25532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Tytgat, “How to isolate cardiac myocytes,” Cardiovascular Research, vol. 28, no. 2, pp. 280–283, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Zhao, J. Zhao, G. He, X. Sun, X. Huang, and L. Hao, “Effects of astragaloside IV on action potentials and ionic currents in guinea-pig ventricular myocytes,” Biological and Pharmaceutical Bulletin, vol. 36, no. 4, pp. 515–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. B. O'Rourke, D. A. Kass, G. F. Tomaselli, S. Kääb, R. Tunin, and E. Marbán, “Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies,” Circulation Research, vol. 84, no. 5, pp. 562–570, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. R. Houser, V. Piacentino III, and J. Weisser, “Abnormalities of calcium cycling in the hypertrophied and failing heart,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 9, pp. 1595–1607, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. E. Grueter, S. A. Abiria, I. Dzhura et al., “L-type Ca2+ channel facilitation mediated by phosphorylation of the β subunit by CaMKII,” Molecular Cell, vol. 23, no. 5, pp. 641–650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. X.-Q. Zhang, J. Wang, J. Song et al., “Regulation of L-type calcium channel by phospholemman in cardiac myocytes,” Journal of Molecular and Cellular Cardiology, vol. 84, pp. 104–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Bryant, C. H. T. Kong, J. Watson, M. B. Cannell, A. F. James, and C. H. Orchard, “Altered distribution of ICa impairs Ca release at the t-tubules of ventricular myocytes from failing hearts,” Journal of Molecular and Cellular Cardiology, vol. 86, pp. 23–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. O. M. Koval, X. Guan, Y. Wu et al., “CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 4996–5000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. H. Fischer, J. Herting, T. Tirilomis et al., “Ca2+/calmodulin-dependent protein kinase II and protein kinase a differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology,” Circulation, vol. 128, no. 9, pp. 970–981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. J. Kamp and J. W. Hell, “Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C,” Circulation Research, vol. 87, no. 12, pp. 1095–1102, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Sanchez-Alonso, A. Bhargava, T. O'Hara et al., “Microdomain-specific modulation of L-type calcium channels leads to triggered ventricular arrhythmia in heart failure,” Circulation Research, vol. 119, no. 8, pp. 944–955, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Balycheva, G. Faggian, A. V. Glukhov, and J. Gorelik, “Microdomain-specific localization of functional ion channels in cardiomyocytes: an emerging concept of local regulation and remodelling,” Biophysical Reviews, vol. 7, no. 1, pp. 43–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Bers and E. Grandi, “Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels,” Journal of Cardiovascular Pharmacology, vol. 54, no. 3, pp. 180–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Ramirez-Correa, S. Cortassa, B. Stanley, W. D. Gao, and A. M. Murphy, “Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 5, pp. 943–953, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. D. Swaminathan, A. Purohit, T. J. Hund, and M. E. Anderson, “Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias,” Circulation Research, vol. 110, no. 12, pp. 1661–1677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. E. Anderson, J. H. Brown, and D. M. Bers, “CaMKII in myocardial hypertrophy and heart failure,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 4, pp. 468–473, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Zhang, M. S. C. Khoo, Y. Wu et al., “Calmodulin kinase II as a target for inhibition in cardiac disease,” Nature Medicine, vol. 11, no. 4, pp. 409–417, 2005. View at Google Scholar